Greenleaf Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Sell |
5,037
-729
| -13% | -$325K | 0.02% | 179 |
|
|
2025
Q1 | $2.8M | Buy |
5,766
+272
| +5% | +$132K | 0.03% | 155 |
|
|
2024
Q4 | $2.21M | Buy |
5,494
+79
| +1% | +$31.8K | 0.02% | 181 |
|
|
2024
Q3 | $2.52M | Buy |
5,415
+19
| +0.4% | +$8.84K | 0.02% | 162 |
|
|
2024
Q2 | $2.53M | Buy |
5,396
+426
| +9% | +$200K | 0.02% | 153 |
|
|
2024
Q1 | $2.08M | Sell |
4,970
-7
| -0.1% | -$2.93K | 0.02% | 176 |
|
|
2023
Q4 | $2.03M | Buy |
4,977
+67
| +1% | +$27.3K | 0.02% | 176 |
|
|
2023
Q3 | $1.71M | Buy |
4,910
+166
| +3% | +$57.7K | 0.02% | 178 |
|
|
2023
Q2 | $1.67M | Sell |
4,744
-255
| -5% | -$89.7K | 0.02% | 185 |
|
|
2023
Q1 | $1.58M | Buy |
4,999
+7
| +0.1% | +$2.21K | 0.02% | 200 |
|
|
2022
Q4 | $1.44M | Buy |
4,992
+362
| +8% | +$105K | 0.02% | 202 |
|
|
2022
Q3 | $1.34M | Sell |
4,630
-30
| -0.6% | -$8.69K | 0.02% | 196 |
|
|
2022
Q2 | $1.31M | Buy |
4,660
+296
| +7% | +$83.4K | 0.02% | 185 |
|
|
2022
Q1 | $1.14M | Buy |
4,364
+667
| +18% | +$174K | 0.01% | 226 |
|
|
2021
Q4 | $812K | Buy |
3,697
+1,607
| +77% | +$353K | 0.01% | 297 |
|
|
2021
Q3 | $379K | Sell |
2,090
-1,061
| -34% | -$192K | ﹤0.01% | 499 |
|
|
2021
Q2 | $635K | Sell |
3,151
-316
| -9% | -$63.7K | 0.01% | 335 |
|
|
2021
Q1 | $745K | Buy |
3,467
+355
| +11% | +$76.3K | 0.01% | 271 |
|
|
2020
Q4 | $735K | Buy |
3,112
+214
| +7% | +$50.5K | 0.01% | 244 |
|
|
2020
Q3 | $789K | Sell |
2,898
-115
| -4% | -$31.3K | 0.01% | 205 |
|
|
2020
Q2 | $875K | Buy |
3,013
+388
| +15% | +$113K | 0.02% | 174 |
|
|
2020
Q1 | $625K | Buy |
2,625
+306
| +13% | +$72.9K | 0.01% | 189 |
|
|
2019
Q4 | $508K | Hold |
2,319
| – | – | 0.01% | 288 |
|
|
2019
Q3 | $393K | Buy |
2,319
+218
| +10% | +$36.9K | 0.01% | 337 |
|
|
2019
Q2 | $385K | Sell |
2,101
-42
| -2% | -$7.7K | 0.01% | 344 |
|
|
2019
Q1 | $394K | Buy |
2,143
+335
| +19% | +$61.6K | 0.01% | 315 |
|
|
2018
Q4 | $300K | Buy |
1,808
+140
| +8% | +$23.2K | 0.01% | 367 |
|
|
2018
Q3 | $321K | Buy |
1,668
+216
| +15% | +$41.6K | 0.01% | 375 |
|
|
2018
Q2 | $247K | Buy |
+1,452
| New | +$247K | ﹤0.01% | 426 |
|
|
2018
Q1 | – | Sell |
-152
| Closed | -$23K | – | 663 |
|
|
2017
Q4 | $23K | Sell |
152
-30
| -16% | -$4.54K | ﹤0.01% | 574 |
|
|
2017
Q3 | $28K | Buy |
+182
| New | +$28K | ﹤0.01% | 515 |
|